Global Multiplexed Diagnostics 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072404193

Publication Date:

July 5, 2024

Pages:

109

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Multiplexed Diagnostics market size was valued at USD 2015 million in 2023 and is forecast to a readjusted size of USD 3356.1 million by 2030 with a CAGR of 7.6% during review period.
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
This report includes an overview of the development of the Multiplexed Diagnostics industry chain, the market status of Academic Research Institutes (Very High Density Multiplexed Assays (Above 10,000-plex), High Density Multiplexed Assays (500 Below plex Below 10,000)), Hospital (Very High Density Multiplexed Assays (Above 10,000-plex), High Density Multiplexed Assays (500 Below plex Below 10,000)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Multiplexed Diagnostics.
Regionally, the report analyzes the Multiplexed Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Multiplexed Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Multiplexed Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Multiplexed Diagnostics industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Very High Density Multiplexed Assays (Above 10,000-plex), High Density Multiplexed Assays (500 Below plex Below 10,000)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Multiplexed Diagnostics market.
Regional Analysis: The report involves examining the Multiplexed Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Multiplexed Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Multiplexed Diagnostics:
Company Analysis: Report covers individual Multiplexed Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Multiplexed Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Academic Research Institutes, Hospital).
Technology Analysis: Report covers specific technologies relevant to Multiplexed Diagnostics. It assesses the current state, advancements, and potential future developments in Multiplexed Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Multiplexed Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Multiplexed Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
麻豆原创 segment by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
麻豆原创 segment by players, this report covers
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Multiplexed Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multiplexed Diagnostics, with revenue, gross margin and global market share of Multiplexed Diagnostics from 2019 to 2024.
Chapter 3, the Multiplexed Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Multiplexed Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Multiplexed Diagnostics.
Chapter 13, to describe Multiplexed Diagnostics research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Multiplexed Diagnostics
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Multiplexed Diagnostics by Type
1.3.1 Overview: Global Multiplexed Diagnostics 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Multiplexed Diagnostics Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Very High Density Multiplexed Assays (Above 10,000-plex)
1.3.4 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.3.5 Medium Density Multiplexed Assays (plex Below 500)
1.3.6 Low Density Multiplexed Assays (plex Below 5)
1.3.7 Next Generation Sequencing Assays
1.4 Global Multiplexed Diagnostics 麻豆原创 by Application
1.4.1 Overview: Global Multiplexed Diagnostics 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Academic Research Institutes
1.4.3 Hospital
1.4.4 Pharmaceutical Companies
1.4.5 Clinical Research Organizations
1.4.6 Diagnostic Laboratories
1.5 Global Multiplexed Diagnostics 麻豆原创 Size & Forecast
1.6 Global Multiplexed Diagnostics 麻豆原创 Size and Forecast by Region
1.6.1 Global Multiplexed Diagnostics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Multiplexed Diagnostics 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Multiplexed Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Multiplexed Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Multiplexed Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Multiplexed Diagnostics 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Multiplexed Diagnostics 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies Multiplexed Diagnostics Product and Solutions
2.1.4 Agilent Technologies Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Product and Solutions
2.2.4 Bio-Rad Laboratories Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 BioMerieux
2.3.1 BioMerieux Details
2.3.2 BioMerieux Major Business
2.3.3 BioMerieux Multiplexed Diagnostics Product and Solutions
2.3.4 BioMerieux Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 BioMerieux Recent Developments and Future Plans
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Product and Solutions
2.4.4 F. Hoffmann-La Roche Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business
2.5.3 Illumina Multiplexed Diagnostics Product and Solutions
2.5.4 Illumina Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Illumina Recent Developments and Future Plans
2.6 Luminex
2.6.1 Luminex Details
2.6.2 Luminex Major Business
2.6.3 Luminex Multiplexed Diagnostics Product and Solutions
2.6.4 Luminex Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Luminex Recent Developments and Future Plans
2.7 Hologic
2.7.1 Hologic Details
2.7.2 Hologic Major Business
2.7.3 Hologic Multiplexed Diagnostics Product and Solutions
2.7.4 Hologic Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Hologic Recent Developments and Future Plans
2.8 Thermo Fisher Scientific
2.8.1 Thermo Fisher Scientific Details
2.8.2 Thermo Fisher Scientific Major Business
2.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Product and Solutions
2.8.4 Thermo Fisher Scientific Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.9 Siemens Healthineers
2.9.1 Siemens Healthineers Details
2.9.2 Siemens Healthineers Major Business
2.9.3 Siemens Healthineers Multiplexed Diagnostics Product and Solutions
2.9.4 Siemens Healthineers Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Siemens Healthineers Recent Developments and Future Plans
2.10 Abbott Laboratories
2.10.1 Abbott Laboratories Details
2.10.2 Abbott Laboratories Major Business
2.10.3 Abbott Laboratories Multiplexed Diagnostics Product and Solutions
2.10.4 Abbott Laboratories Multiplexed Diagnostics Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Abbott Laboratories Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Multiplexed Diagnostics Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Multiplexed Diagnostics by Company Revenue
3.2.2 Top 3 Multiplexed Diagnostics Players 麻豆原创 Share in 2023
3.2.3 Top 6 Multiplexed Diagnostics Players 麻豆原创 Share in 2023
3.3 Multiplexed Diagnostics 麻豆原创: Overall Company Footprint Analysis
3.3.1 Multiplexed Diagnostics 麻豆原创: Region Footprint
3.3.2 Multiplexed Diagnostics 麻豆原创: Company Product Type Footprint
3.3.3 Multiplexed Diagnostics 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Multiplexed Diagnostics Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Multiplexed Diagnostics 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Multiplexed Diagnostics Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Multiplexed Diagnostics 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Multiplexed Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Multiplexed Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Multiplexed Diagnostics 麻豆原创 Size by Country
6.3.1 North America Multiplexed Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Multiplexed Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Multiplexed Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Multiplexed Diagnostics 麻豆原创 Size by Country
7.3.1 Europe Multiplexed Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Multiplexed Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Multiplexed Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Multiplexed Diagnostics 麻豆原创 Size by Region
8.3.1 Asia-Pacific Multiplexed Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Multiplexed Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Multiplexed Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Multiplexed Diagnostics 麻豆原创 Size by Country
9.3.1 South America Multiplexed Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Multiplexed Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Multiplexed Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Multiplexed Diagnostics 麻豆原创 Size by Country
10.3.1 Middle East & Africa Multiplexed Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Multiplexed Diagnostics 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Multiplexed Diagnostics 麻豆原创 Drivers
11.2 Multiplexed Diagnostics 麻豆原创 Restraints
11.3 Multiplexed Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Multiplexed Diagnostics Industry Chain
12.2 Multiplexed Diagnostics Upstream Analysis
12.3 Multiplexed Diagnostics Midstream Analysis
12.4 Multiplexed Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.